ZappRx taps former Walgreens specialty exec to drive growth

BOSTON — Specialty prescribing platform ZappRx announced Wednesday that Lorrie Carr would be joining the company as its chief commercial officer. Most recently, Carr was Walgreens’ divisional VP enterprise specialty sales and product management. Carr will oversee ZappRx’s commercialization efforts as it launches and looks to expand its specialty prescribing and management platform. 

 

“Lorrie is joining ZappRx at the perfect time as we initiate the launch of our platform within multiple specialty categories and deepen our data footprint," ZappRx founder and CEO Zoë Barry said. “Her expertise in the biopharmaceutical and specialty pharmacy markets will be essential as we expand our relationships and integrations with specialty pharmacies and other industry partners.”

 

The company is launching at a time when specialty drugs make up 40% of drug spending and 2% of all written prescriptions. ZappRx looks to modernize and simplify the way specialty medications are managed. 

 

“I am joining ZappRx at a time when the specialty pharmaceutical industry is at a critical inflection point,” Carr said. “Both the number of available therapies and the costs of these drugs have increased significantly over the last several years. Yet drug manufacturers and other stakeholders lack the real-time, clinical data necessary to measure and improve the fulfillment process, sales performance, and outcomes. ZappRx is taking an innovative approach to improving patient access to specialty therapy while generating critical information for manufacturers and payers.”